Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,771
Award facts
- Contract value 100% obligated
- $13,771.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,771.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on January 21, 2026, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Zepbound is a pharmaceutical product used in diabetes and weight management treatment, reflecting the Defense Logistics Agency's ongoing procurement of specialty medications to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency valued up to $999,999,999 through December 2031. That prime contract vehicle serves as the primary mechanism for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. AmerisourceBergen's consistent competitively awarded contract performance demonstrates its capability to efficiently fulfill critical pharmaceutical procurement requirements for federal military treatment facilities and healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FN0T3?
SPE2DR26FN0T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FN0T3 worth?
The government has obligated $13,771 on SPE2DR26FN0T3.
Is contract SPE2DR26FN0T3 an order under another contract?
Yes. SPE2DR26FN0T3 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0T3 competed?
The extent of competition for SPE2DR26FN0T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award